Specifically concerning this last point, one could hypothesize that the numerical enlargement of the naïve CD4+CD25− T cell pool transferred to lymphopenic recipients might be paradoxically beneficial for the suppression of colitis, as the source of relevant clones available for peripheral conversion to Foxp3+ cells would be also presumably broadened. The gene discussed is FOXP3; the disease is colitis.